| scholarly article | Q13442814 |
| P356 | DOI | 10.2165/00023210-199401030-00005 |
| P698 | PubMed publication ID | 27520519 |
| P50 | author | Sidney H. Kennedy | Q59560583 |
| P2093 | author name string | D S Goldbloom | |
| P2860 | cites work | Comorbidity of psychiatric diagnoses in anorexia nervosa. | Q52049291 |
| Fluoxetine treatment of anorexia nervosa: an open clinical trial. | Q52056267 | ||
| The depressive symptoms of bulimia nervosa. | Q52079580 | ||
| A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa. | Q52235673 | ||
| To be or not be a woman: anorexia nervosa, normative gender roles, and feminism. | Q53682669 | ||
| An open trial of fluoxetine in patients with anorexia nervosa | Q54073316 | ||
| A double-blind controlled trial of lithium carbonate primary anorexia nervosa. | Q54728491 | ||
| Treatment of bulimia with fenfluramine and desipramine | Q61050715 | ||
| Mineral balance and bone turnover in adolescents with anorexia nervosa | Q61479256 | ||
| Predictors of osteopenia in premenopausal women with anorexia nervosa | Q61766658 | ||
| Increased pulse and blood pressure associated with desipramine treatment of bulimia nervosa | Q28320827 | ||
| Outcome and clinical course in inpatient bulimic women: a 2- to 9-year follow-up study | Q28328306 | ||
| Delayed gastrointestinal transit times in anorexia nervosa and bulimia nervosa. | Q33442444 | ||
| Phenelzine vs placebo in 50 patients with bulimia | Q34172163 | ||
| An evaluation of family therapy in anorexia nervosa and bulimia nervosa. | Q34174024 | ||
| Studies of the epidemiology of bulimia nervosa | Q34204934 | ||
| Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study | Q34268551 | ||
| Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin | Q34512734 | ||
| Determinants of delayed gastric emptying in anorexia nervosa and bulimia nervosa | Q34529763 | ||
| Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa | Q34530873 | ||
| The genetic epidemiology of bulimia nervosa | Q34771318 | ||
| Bulimia nervosa : a review of therapy research. | Q35899652 | ||
| Psychopharmacologic treatment of bulimia nervosa | Q37457608 | ||
| Is anorexia nervosa an obsessive-compulsive disorder? | Q37951678 | ||
| The serotonin hypothesis of bulimia nervosa: theory and evidence | Q38028898 | ||
| A controlled trial of d-fenfluramine in bulimia nervosa. | Q39534731 | ||
| Altered gastric emptying and secretion in primary anorexia nervosa | Q41048493 | ||
| Treatment of bulimia nervosa with lithium carbonate. A controlled study | Q42005477 | ||
| A trial of isocarboxazid in the treatment of bulimia nervosa | Q42207101 | ||
| Psychiatric comorbidity in treatment-seeking anorexics and bulimics | Q44309996 | ||
| Lack of association between fluoxetine and suicidality in bulimia nervosa | Q44494482 | ||
| Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison | Q44578955 | ||
| Long-term outcome of antidepressant treatment for bulimia nervosa | Q44643155 | ||
| A serial study of gastric emptying in anorexia nervosa and bulimia | Q45114022 | ||
| Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study | Q45196653 | ||
| The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression. | Q47189791 | ||
| How abnormal is the desire for slimness? A survey of eating attitudes and behaviour among Chinese undergraduates in Hong Kong. | Q47262676 | ||
| Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population | Q47300882 | ||
| Osteoporosis and normal weight bulimia nervosa--which patients are at risk? | Q47395395 | ||
| Carbamazepine in the treatment of bulimia | Q48747361 | ||
| Dieting reduces plasma tryptophan and alters brain 5-HT function in women | Q48863231 | ||
| A placebo-controlled crossover study of oral clonidine in acute anorexia nervosa | Q48964387 | ||
| Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. | Q51138935 | ||
| A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. | Q51169661 | ||
| A placebo-controlled, double-blind trial of amitriptyline in bulimia. | Q51231618 | ||
| Zinc deficiency and childhood-onset anorexia nervosa. | Q51602066 | ||
| How Common is Anorexia Nervosa? A Prevalence Study | Q67461169 | ||
| Zinc status before and after zinc supplementation of eating disorder patients | Q67600290 | ||
| Reduced bone density and major hormones regulating calcium metabolism in anorexia nervosa | Q67990863 | ||
| Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group | Q68077415 | ||
| Treatment of bulimia with desipramine: a double-blind crossover study | Q68136733 | ||
| Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program | Q68433977 | ||
| Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatment | Q68519543 | ||
| A prospective study of eating disturbances in the ballet | Q68846963 | ||
| Anorexia nervosa. Treatment efficacy of cyproheptadine and amitriptyline | Q68860307 | ||
| Treating bulimia with desipramine. A double-blind, placebo-controlled study | Q68860310 | ||
| Brief psychotherapy in the treatment of anorexia nervosa. Outcome at one year | Q69465402 | ||
| Long-term follow-up of anorexia nervosa | Q69627811 | ||
| Psychiatric disorders in the first-degree relatives of probands with bulimia nervosa | Q69801739 | ||
| Affective disturbance in eating disorders | Q69839926 | ||
| Amitriptyline in the treatment of anorexia nervosa: a double-blind, placebo-controlled study | Q70061125 | ||
| Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy | Q70132232 | ||
| Bulimia treated with imipramine: a placebo-controlled, double-blind study | Q70254558 | ||
| Neuroleptics in the short-term treatment of anorexia nervosa. A double- blind placebo-controlled study with sulpiride | Q70330957 | ||
| Clinical findings in patients with anorexia nervosa and affective illness in their relatives | Q70664693 | ||
| Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change | Q70677253 | ||
| Osteoporosis in women with anorexia nervosa | Q70683085 | ||
| Treatment of bulimia with antidepressants | Q71636620 | ||
| A placebo-controlled trial of d-fenfluramine in bulimia nervosa | Q72343190 | ||
| Fluoxetine: the relationship between response, adverse events, and plasma concentrations in the treatment of bulimia nervosa | Q72695755 | ||
| Treatment and outcome of anorexia nervosa | Q72799313 | ||
| A new treatment of anorexia nervosa | Q79205358 | ||
| P433 | issue | 3 | |
| P921 | main subject | anorexia nervosa | Q131749 |
| bulimia nervosa | Q64513386 | ||
| P304 | page(s) | 201-212 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa | |
| P478 | volume | 1 |
Search more.